Last reviewed · How we verify
Enduron (methylclothiazide)
Enduron (generic name: methylclothiazide) is a Thiazide Diuretic drug. It is currently FDA-approved (first approved 1960) for Edema, Hypertensive disorder, Peripheral Edema due to Chronic Heart Failure.
Enduron is a small molecule that inhibits the thiazide-sensitive sodium-chloride cotransporter, and it has been studied in clinical trials for various conditions including osteoarthritis, post-traumatic arthritis, and avascular necrosis.
At a glance
| Generic name | methylclothiazide |
|---|---|
| Drug class | Thiazide Diuretic |
| Target | Solute carrier family 12 member 3 |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1960 |
Approved indications
- Edema
- Hypertensive disorder
- Peripheral Edema due to Chronic Heart Failure
- Pulmonary Edema due to Chronic Heart Failure
- Renal Disease with Edema
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Enduron CI brief — competitive landscape report
- Enduron updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Enduron
What is Enduron?
What is Enduron used for?
What is the generic name of Enduron?
What drug class is Enduron in?
When was Enduron approved?
What development phase is Enduron in?
What does Enduron target?
Related
- Drug class: All Thiazide Diuretic drugs
- Target: All drugs targeting Solute carrier family 12 member 3
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Edema
- Indication: Drugs for Hypertensive disorder
- Indication: Drugs for Peripheral Edema due to Chronic Heart Failure
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing